Cargando…
How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi
BACKGROUND: Pregnant and breastfeeding women are at an increased risk of severe illness from COVID-19 compared to people who are not pregnant. Therefore, the CDC recommends COVID-19 vaccination for women who are pregnant, breastfeeding, and trying to become pregnant or who may become pregnant in the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594199/ http://dx.doi.org/10.1093/eurpub/ckac129.665 |
_version_ | 1784815355183497216 |
---|---|
author | Bianchi, FP Stefanizzi, P Di Gioia, MC Brescia, N Lattanzio, S Tafuri, S |
author_facet | Bianchi, FP Stefanizzi, P Di Gioia, MC Brescia, N Lattanzio, S Tafuri, S |
author_sort | Bianchi, FP |
collection | PubMed |
description | BACKGROUND: Pregnant and breastfeeding women are at an increased risk of severe illness from COVID-19 compared to people who are not pregnant. Therefore, the CDC recommends COVID-19 vaccination for women who are pregnant, breastfeeding, and trying to become pregnant or who may become pregnant in the future. Despite this, low vaccination coverages are reported in this population sub-group. The purpose of this study is to estimate the proportion of pregnant and breastfeeding women expressing hesitation to the COVID-19 vaccine worldwide. Determinants of vaccine compliance and options suggestedto address vaccine hesitancy were also analyzed. METHODS: Forty-six studies were included in the meta-analysis and systematic review, selected from scientific articles available in the MEDLINE/PubMed, Google Scholar, and Scopus databases between January 1, 2020 and February 6, 2022. The following terms were used for the search strategy: (adherence OR hesitancy OR compliance OR attitude) AND (covid* OR SARS*) AND (vaccin* OR immun*) AND (pregnan* OR post-partum OR breastfeeding OR lactating). RESULTS: The vaccine hesitation rate was 48.4% (95%CI=43.4-53.4%). In a sub analysis by study period, the pooled prevalence of vaccine hesitation was 40.0% (95%CI=31.6-46.6%) considering surveys administered in 2020, 58.0% (95%CI=48.9-66.9%) considering surveys administered in the first semester of 2021, and 38.1% (95%CI=25.9-51.2%) considering surveys administered in the second semester of 2021. The main reasons for vaccine hesitation were lack of information about vaccination, opinion that the vaccine is unsafe, and fear of adverse events for both mother and fetus/child. CONCLUSIONS: In order to achieve high vaccination coverage, a multifactorial approach is needed, requiring major social, scientific, and health efforts. The success of the vaccination campaign in this population depends on the capillarity and consistency of the interventions implemented. KEY MESSAGES: • Vaccine hesitancy can be a determining factor in the success (or otherwise) of the anti-COVID-19 immunization campaign. • Vaccine hesitancy in pregnant and breastfeeding women is a genuine public health concern worldwide. |
format | Online Article Text |
id | pubmed-9594199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95941992022-11-04 How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi Bianchi, FP Stefanizzi, P Di Gioia, MC Brescia, N Lattanzio, S Tafuri, S Eur J Public Health Parallel Programme BACKGROUND: Pregnant and breastfeeding women are at an increased risk of severe illness from COVID-19 compared to people who are not pregnant. Therefore, the CDC recommends COVID-19 vaccination for women who are pregnant, breastfeeding, and trying to become pregnant or who may become pregnant in the future. Despite this, low vaccination coverages are reported in this population sub-group. The purpose of this study is to estimate the proportion of pregnant and breastfeeding women expressing hesitation to the COVID-19 vaccine worldwide. Determinants of vaccine compliance and options suggestedto address vaccine hesitancy were also analyzed. METHODS: Forty-six studies were included in the meta-analysis and systematic review, selected from scientific articles available in the MEDLINE/PubMed, Google Scholar, and Scopus databases between January 1, 2020 and February 6, 2022. The following terms were used for the search strategy: (adherence OR hesitancy OR compliance OR attitude) AND (covid* OR SARS*) AND (vaccin* OR immun*) AND (pregnan* OR post-partum OR breastfeeding OR lactating). RESULTS: The vaccine hesitation rate was 48.4% (95%CI=43.4-53.4%). In a sub analysis by study period, the pooled prevalence of vaccine hesitation was 40.0% (95%CI=31.6-46.6%) considering surveys administered in 2020, 58.0% (95%CI=48.9-66.9%) considering surveys administered in the first semester of 2021, and 38.1% (95%CI=25.9-51.2%) considering surveys administered in the second semester of 2021. The main reasons for vaccine hesitation were lack of information about vaccination, opinion that the vaccine is unsafe, and fear of adverse events for both mother and fetus/child. CONCLUSIONS: In order to achieve high vaccination coverage, a multifactorial approach is needed, requiring major social, scientific, and health efforts. The success of the vaccination campaign in this population depends on the capillarity and consistency of the interventions implemented. KEY MESSAGES: • Vaccine hesitancy can be a determining factor in the success (or otherwise) of the anti-COVID-19 immunization campaign. • Vaccine hesitancy in pregnant and breastfeeding women is a genuine public health concern worldwide. Oxford University Press 2022-10-25 /pmc/articles/PMC9594199/ http://dx.doi.org/10.1093/eurpub/ckac129.665 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Parallel Programme Bianchi, FP Stefanizzi, P Di Gioia, MC Brescia, N Lattanzio, S Tafuri, S How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi |
title | How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi |
title_full | How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi |
title_fullStr | How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi |
title_full_unstemmed | How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi |
title_short | How to deal with COVID-19 vaccine hesitancy in pregnant and breastfeeding women? A meta-analysis: Francesco Paolo Bianchi |
title_sort | how to deal with covid-19 vaccine hesitancy in pregnant and breastfeeding women? a meta-analysis: francesco paolo bianchi |
topic | Parallel Programme |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594199/ http://dx.doi.org/10.1093/eurpub/ckac129.665 |
work_keys_str_mv | AT bianchifp howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi AT stefanizzip howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi AT digioiamc howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi AT brescian howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi AT lattanzios howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi AT tafuris howtodealwithcovid19vaccinehesitancyinpregnantandbreastfeedingwomenametaanalysisfrancescopaolobianchi |